Biochemist who discovered GLP-1 named winner of 2026 Kimberly Prize Svetlana Mojsovs studies have led to 'life-changing therapies for type 2 diabetes and obesity' Mojsovs studies demonstrated that GLP-1 stimulates insulin secretion and lowers blood glucose levels, which led to the development of GLP-1 receptor agonists, including semaglutide The $250,000 prize winner will also deliver a public lecture on the Feinberg campus in Chicago Mojsovs career in the laboratory has had a profound impact on human heath globally CHICAGO --- Northwestern University Feinberg School of Medicine and the Simpson Querrey Institute for Epigenetics announced today (Oct
We will collaborate closely with you to track your development, talk about any possible drug interactions, and modify your treatment plan as needed
Waser, B., Beetschen, K., Pellegata, N
Email is the most reliable channel
establishing longitudinal monitoring frameworks to elucidate doseresponse relationships and temporal patterns
instead, we follow a careful titration schedule
